ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 52 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $973,000 | -89.9% | 59,273 | -90.7% | 0.40% | -89.9% |
| Q2 2016 | $9,646,000 | -20.3% | 637,128 | -23.9% | 3.92% | -34.7% |
| Q1 2016 | $12,105,000 | -48.9% | 837,128 | 0.0% | 5.99% | -54.2% |
| Q4 2015 | $23,707,000 | +7.9% | 837,128 | -36.2% | 13.09% | +8.0% |
| Q3 2015 | $21,965,000 | -43.2% | 1,312,128 | -11.0% | 12.12% | -33.1% |
| Q2 2015 | $38,661,000 | +33.1% | 1,474,482 | -11.3% | 18.12% | +95.3% |
| Q1 2015 | $29,037,000 | -16.9% | 1,662,128 | -17.4% | 9.28% | -18.1% |
| Q4 2014 | $34,951,000 | – | 2,012,128 | – | 11.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| C Partners Holding GmbH | 1,662,128 | $29,037,000 | 9.28% |
| GREAT POINT PARTNERS LLC | 608,650 | $10,645,000 | 4.68% |
| Opaleye Management Inc. | 255,000 | $4,460,000 | 2.07% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 326,530 | $5,721,000 | 0.47% |
| Granite Point Capital Management, L.P. | 61,813 | $1,076,000 | 0.39% |
| WALL STREET ASSOCIATES | 225,000 | $3,935,000 | 0.37% |
| EMERALD ADVISERS, LLC | 322,631 | $5,652,000 | 0.28% |
| Spark Investment Management LLC | 75,500 | $1,317,000 | 0.18% |
| TFS CAPITAL LLC | 98,443 | $1,722,000 | 0.17% |
| PRIVATE ASSET MANAGEMENT INC | 47,690 | $834,000 | 0.14% |